Generic Name: Bortezomib Therapeutic Class:Therapeutic Class Indications Bortez is a proteasome inhibitor indicated for: Pharmacology Bortezomib for Injection is an antineoplastic agent available for intravenous (IV) and subcutaneous injection use. It is a reversible inhibitor of the chymotrypsin-like activity of the 26S proteasome in mammalian cells. The 26S proteasome is a large protein complex that […]